Dihydroergotamine Mesylate Injection — Class II drug recall D-0150-2025
Ongoing recall by Provepharm Inc., reported 2024-12-25, distributed nationwide. Discoloration
| Recall number | D-0150-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Provepharm Inc., Collegeville, PA, United States |
| Recall initiated | 2024-11-22 |
| Classified | 2024-12-16 |
| Reported by FDA | 2024-12-25 |
| Distributed | Nationwide (US) |
| NDC | 81284-0411, 81284-0411-00, 81284-0411-05, 81284-0411-10 |
| Lot numbers | F9026F01, F9026F02 |
| Expiration dates | 2025-12 |
Product
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05
Reason for recall
Discoloration
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0150-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.